FeesSafety
Pluang+

REX Crypto Equity Premium Income ETF sells calls limiting rally gains, payout trends lower, rated Sell.

Market News
13 Nov 2026, 20:18 WIB
Seeking Alpha
View Source
Bearish
REX Crypto Equity Premium Income ETF sells calls limiting rally gains, payout trends lower, rated Sell.

The REX Crypto Equity Premium Income ETF (CEPI) sells call options on 98.4% of its portfolio at or below current prices of major holdings like Mastercard, Visa, and Tesla, which limits its ability to benefit from price rallies. Although the fund's holdings have improved since launch, a significant portion (33.5%) trades at zero or negative price-to-earnings ratios, and the option strategy overshadows the quality of the underlying stocks. Since inception, CEPI has paid out $44 million more than it earned, with 100% of its 2026 distributions being a return of capital. The weekly payout is also trending lower, leading the analyst to rate CEPI as a Sell, suggesting the distribution yield would need to drop closer to 12% to be attractive for income investors.

The REX Crypto Equity Premium Income ETF (CEPI) is discussed here, with Pluang's market snapshot providing context as of Nov 14, 2026 00:11 WIB: Among 150 priced US stocks tradable on Pluang, 74 rose and 75 fell today. Notable movers include MRVL at USD 154.40 with a 1-day change of -6.11% and a typical hold time of 46 days, FIRY at USD 11.35 down 5.81% with a 14-day hold time, and CSCO at USD 96.16 down 5.73% with a typical hold time of 87 days. Pluang order activity shows mixed buy/sell interest across these stocks.

More News

Organic Grower Summit 2026 adds live ag tech demos at Reservoir Farms for hands-on grower experience

Organic Grower Summit 2026 adds live ag tech demos at Reservoir Farms for hands-on grower experience

The Organic Grower Summit (OGS) 2026, held Dec. 2–3 in Monterey, California, introduces an exclusive offsite AGTech Reception & Field Demos at Reservoir Farms. Sponsored by John Deere, Western Growers Association, and Reservoir, this event offers gro...

Others
Bullish
58 minutes ago
New brain cancer drug data and trials spotlighted at Society for Neuro-Oncology meeting

New brain cancer drug data and trials spotlighted at Society for Neuro-Oncology meeting

At the 31st Annual Society for Neuro-Oncology meeting, biotech firms NeOnc, Nuvation Bio, Jazz Pharmaceuticals, and Cerenome presented new clinical data on brain cancer treatments. Highlights include NeOnc's NEO100 and NEO212 therapies advancing towa...

Market News
Bullish
1 hour ago
Subsea 7 wins $50M-$150M contract for deepwater project in US Gulf of Mexico starting 2028

Subsea 7 wins $50M-$150M contract for deepwater project in US Gulf of Mexico starting 2028

Subsea 7 has secured a sizeable contract from Kosmos Energy for the Tiberius Project in the US Gulf of Mexico, involving fabrication and installation of subsea infrastructure at about 2,200 meters depth. The work includes a 14-kilometer steel riser, ...

Market News
Bullish
1 hour ago
GlobeNewswire issues daily market update with no new financial news on Nov 13, 2026

GlobeNewswire issues daily market update with no new financial news on Nov 13, 2026

GlobeNewswire released its End of Day Message for November 13, 2026, confirming its role as an FCA-approved primary information provider. The update mainly reiterates its operational status and disclaimers, without reporting any new financial events ...

Market News
Neutral
1 hour ago
Space42 reports 11% revenue growth and 30% jump in normalized EBITDA for first nine months of 2026

Space42 reports 11% revenue growth and 30% jump in normalized EBITDA for first nine months of 2026

Space42, a UAE-based space technology company, announced strong financial results for the first nine months of 2026, with revenue up 11% to $404 million and normalized EBITDA rising 30% to $194 million. Growth was driven by its two main divisions: Sp...

Company Fundamentals
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App